C

Cutera
D

CUTR

0.31910
USD
0.01
(3.07%)
Market Closed
Volume
8,509
EPS
2
Div Yield
-
P/E
-0
Market Cap
6,441,329
OverviewSignalsIdeasNews
Related Instruments
    A
    A
    -3.140
    (-2.41%)
    127.100 USD
    AMGN
    AMGN
    -12.22
    (-4.13%)
    294.4 USD
    AMP
    AMP
    0.99
    (0.18%)
    562.53 USD
    BDX
    BDX
    -2.040
    (-0.90%)
    225.190 USD
    BMY
    BMY
    -2.270
    (-3.88%)
    56.230 USD
    BSX
    BSX
    -0.590
    (-0.67%)
    87.000 USD
    C
    CAH
    -2.540
    (-2.09%)
    118.790 USD
    CI
    CI
    -2.54
    (-0.78%)
    321.53 USD
    C
    COO
    -0.230
    (-0.23%)
    99.640 USD
    CVS
    CVS
    -1.920
    (-3.48%)
    53.190 USD
    D
    DGX
    3.615
    (2.30%)
    160.455 USD
    EW
    EW
    1.620
    (2.45%)
    67.780 USD
    GILD
    GILD
    -3.715
    (-4.03%)
    88.385 USD
    HUM
    HUM
    -7.25
    (-2.56%)
    275.68 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    155.14 USD
    MDT
    MDT
    1.520
    (1.77%)
    86.2 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    99.16 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.63 USD
    Z
    ZBH
    3.638
    (3.34%)
    112.490 USD
    More
News

Title: Cutera

Sector: Healthcare
Industry: Medical Devices
Cutera Inc is a medical device company that specializes in designing, developing, manufacturing, marketing, and servicing laser and other energy-based aesthetics systems for practitioners internationally. Its products include enlighten, excel HR, excel V, Xeo and Trusculpt 3D among others. The company markets and sells its products under the trademarks such as Cutera, Acutip, Coolglide, Enlighten, Excel HR, Excel V, Genesis plus, Pico-genesis, Titan, Trusculpt, and Xeo amongothers. It derives the majority of its revenue from the United States segment. Its products enable medical practitioners to perform safe procedures including treatment for acne, body contouring, skin resurfacing and revitalization, hair and tattoo removal, removal of benign pigmented lesions, and vascular conditions.